Subtopic Deep Dive

Protein Formulation Stability
Research Guide

What is Protein Formulation Stability?

Protein Formulation Stability examines excipient effects, pH, and storage conditions on colloidal and conformational stability of antibodies and recombinant proteins using accelerated stability testing and predictive modeling.

This subtopic focuses on formulation strategies to prevent protein aggregation and maintain bioactivity during storage and delivery. Key methods include lyophilization and use of stabilizers like cyclodextrins and polysorbates. Over 10 highly cited papers, such as Mitragotri et al. (2014, 1584 citations) and Wang (2000, 1140 citations), address these challenges.

Curated Papers

Key Challenges

Why It Matters

Robust protein formulations extend shelf-life of biologics, enabling global drug distribution and improving patient access to therapies like monoclonal antibodies. Mitragotri et al. (2014) highlight formulation strategies overcoming administration challenges for biopharmaceuticals. Wang (2000) details lyophilization for solid protein pharmaceuticals, critical for vaccines and injectables. Manning et al. (1989) establish foundational stability principles applied in commercial products.

Key Research Challenges

Preventing Protein Aggregation

Aggregation pathways induced by formulation stress compromise efficacy and safety. Mahler et al. (2008) analyze induction factors and detection methods. Cromwell et al. (2006) link bioprocessing to aggregation risks in production.

Optimizing Excipient Selection

Excipients like polysorbates degrade over time, affecting stability. Kerwin (2007) maps degradation pathways of polysorbates 20 and 80 in protein formulations. Challa et al. (2005) review cyclodextrins for drug delivery stabilization.

Ensuring Colloidal Stability

pH and storage conditions alter colloidal stability, leading to phase separation. Hawe et al. (2008) use extrinsic fluorescent dyes to measure surface hydrophobicity and aggregation. van de Weert et al. (2000) study protein instability in PLGA microparticles.

Essential Papers

Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

Samir Mitragotri, Paul A. Burke, Róbert Langer · 2014 · Nature Reviews Drug Discovery · 1.6K citations

Cyclodextrins in drug delivery: An updated review

Rajeswari Challa, Alka Ahuja, Javed Ali et al. · 2005 · AAPS PharmSciTech · 1.2K citations

Extrinsic Fluorescent Dyes as Tools for Protein Characterization

Andrea Hawe, Marc Sutter, Wim Jiskoot · 2008 · Pharmaceutical Research · 1.2K citations

Noncovalent, extrinsic fluorescent dyes are applied in various fields of protein analysis, e.g. to characterize folding intermediates, measure surface hydrophobicity, and detect aggregation or fibr...

Lyophilization and development of solid protein pharmaceuticals

Wei Wang · 2000 · International Journal of Pharmaceutics · 1.1K citations

Stability of Protein Pharmaceuticals

Mark C. Manning, Kamlesh C. Patel, Ronald T. Borchardt · 1989 · Pharmaceutical Research · 1.1K citations

Protein aggregation: Pathways, induction factors and analysis

Hanns‐Christian Mahler, Wolfgang Frieß, Ulla Grauschopf et al. · 2008 · Journal of Pharmaceutical Sciences · 873 citations

Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways

Bruce A. Kerwin · 2007 · Journal of Pharmaceutical Sciences · 767 citations

Reading Guide

Foundational Papers

Start with Manning et al. (1989, 1072 citations) for core stability principles, then Wang (2000, 1140 citations) for lyophilization fundamentals, and Mitragotri et al. (2014, 1584 citations) for formulation-delivery integration.

Recent Advances

Study Kerwin (2007, 767 citations) on polysorbate degradation and Patil et al. (2015, 537 citations) on hot-melt extrusion for solid formulations.

Core Methods

Core techniques: extrinsic dyes for characterization (Hawe 2008), cyclodextrins for delivery (Challa 2005), and aggregation pathway analysis (Mahler 2008).

How PapersFlow Helps You Research Protein Formulation Stability

Discover & Search

PapersFlow's Research Agent uses searchPapers and citationGraph to map high-impact works like Mitragotri et al. (2014, 1584 citations), then findSimilarPapers reveals related stability studies on excipients. exaSearch uncovers niche papers on accelerated testing beyond top results.

Analyze & Verify

Analysis Agent applies readPaperContent to extract aggregation data from Mahler et al. (2008), verifies claims with CoVe chain-of-verification, and runs PythonAnalysis for statistical modeling of stability kinetics using NumPy/pandas on extracted datasets. GRADE grading scores evidence strength for excipient efficacy claims.

Synthesize & Write

Synthesis Agent detects gaps in polysorbate degradation coverage (Kerwin 2007), flags contradictions between lyophilization methods (Wang 2000), and uses exportMermaid for stability pathway diagrams. Writing Agent employs latexEditText, latexSyncCitations, and latexCompile to generate formulation review manuscripts.

Use Cases

"Analyze aggregation kinetics from fluorescent dye data in Hawe et al. 2008"

Analysis Agent → readPaperContent (Hawe 2008) → runPythonAnalysis (fit exponential decay models with matplotlib plots) → researcher gets quantified aggregation rates and visualizations.

"Draft LaTeX review on lyophilization for protein stability citing Wang 2000"

Synthesis Agent → gap detection → Writing Agent → latexEditText (structure sections) → latexSyncCitations (Wang 2000 et al.) → latexCompile → researcher gets compiled PDF with bibliography.

"Find GitHub repos with code for protein stability predictive models"

Research Agent → searchPapers (stability modeling) → Code Discovery (paperExtractUrls → paperFindGithubRepo → githubRepoInspect) → researcher gets vetted repos with ML scripts for formulation prediction.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ stability papers, chaining citationGraph from Mitragotri (2014) to generate structured reports on excipient trends. DeepScan applies 7-step analysis with CoVe checkpoints to verify aggregation claims in Mahler (2008). Theorizer generates hypotheses on novel stabilizer combinations from Wang (2000) and Kerwin (2007) literature.

Try Doxa for Protein Formulation Stability Research

Frequently Asked Questions

What defines Protein Formulation Stability?

It examines excipient effects, pH, and storage on colloidal/conformational stability of proteins via accelerated testing and modeling.

What are key methods in protein formulation stability?

Methods include lyophilization (Wang 2000), extrinsic fluorescent dyes for aggregation (Hawe 2008), and polysorbate stabilization (Kerwin 2007).

What are the most cited papers?

Mitragotri et al. (2014, 1584 citations) on biopharmaceutical formulations; Wang (2000, 1140 citations) on lyophilization; Manning et al. (1989, 1072 citations) on protein stability.

What are open problems in this subtopic?

Challenges persist in predicting long-term polysorbate degradation (Kerwin 2007) and mitigating aggregation in novel delivery systems like PLGA (van de Weert 2000).